Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study

Media coverage

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	Plus Company Updates (PCU)
  Country	United States
  Date	4/10/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	BioSpace
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	SPi World News
  Country	United Kingdom
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	Nasdaq
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	Yahoo! Finance
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	PM 360
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	4 Traders
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	TeleTrader.com
  Country	Austria
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	Stockwatch
  Country	Canada
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	Customer Zone 360.com
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	India Pharma News
  Country	India
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	PharmiWeb
  Country	United Kingdom
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	PipelineReview
  Country	Spain
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	Pharmacy Choice
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	GlobeNewswire
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	Daily Times Leader
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	BizWire Express
  Country	India
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	PrimeNewswire (Top News)
  Country	United States
  Date	4/3/17
  Persons	John C Browning

• Title	Amicus Therapeutics Completes Enrollment in ESSENCE Phase 3 Epidermolysis Bullosa Clinical Study
  Media name/outlet	World News Report
  Country	United States
  Date	4/3/17
  Persons	John C Browning